Catalyst (CPRX) Reports Q2 Earnings: What Key Metrics Have to Say

Catalyst Pharmaceutical (CPRX) reported $122.71 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 23.2%. EPS of $0.56 for the same period compares to $0.33 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $111.76 million, representing a surprise of +9.80%. The company delivered an EPS surprise of +33.33%, with the consensus EPS estimate being $0.42. While investors closely watch year-over-year changes in headline numbers -- revenue and ...